ICU MEDICAL INC (ICUI) Stock Earnings Estimates
NASDAQ:ICUI • US44930G1076
146.99 USD
-3.59 (-2.38%)
At close: Mar 2, 2026
144.7 USD
-2.29 (-1.56%)
Pre-Market: 3/3/2026, 5:08:21 AM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.28B 73.21% | 2.259B -0.92% | 2.382B 5.44% | 2.25B -5.54% | 2.197B -2.36% | 2.287B 4.10% | 2.644B 15.61% | 2.737B 3.52% | |
| EBITDA YoY % growth | 263.7M 14.11% | 292.857M 11.06% | 322.316M 10.06% | 408.54M 26.75% | 426.27M 4.34% | 463.72M 8.79% | 510.31M 10.05% | 648.72M 27.12% | |
| EBIT YoY % growth | 28.5M -79.84% | 64.083M 124.85% | 102.804M 60.42% | 331.11M 222.08% | 356.1M 7.55% | 392.41M 10.20% | 441.46M 12.50% | N/A | |
| Operating Margin | 1.25% | 2.84% | 4.32% | 14.72% | 16.21% | 17.16% | 16.70% | N/A | |
| EPS YoY % growth | 6.54 -11.50% | 6.76 3.36% | 6.22 -7.99% | 7.67 24.76% | 8.20 5.70% | 9.46 15.28% | 11.94 26.32% | 12.27 2.73% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.80 4.37% | 1.96 -6.63% | 2.06 1.61% | 2.26 18.18% | 2.13 18.69% | 2.28 16.13% | 2.35 13.99% | 2.54 12.70% |
| Revenue Q2Q % growth | 532.75M -11.13% | 542.9M -0.12% | 559.47M 4.91% | 560.49M 4.58% | 557.33M 4.61% | 564.06M 3.90% | 581.2M 3.88% | 581.2M 3.69% |
| EBITDA Q2Q % growth | 98.056M 24.07% | 102.92M -18.26% | 107.66M -39.10% | 110.62M 14.26% | 111.69M 13.90% | 113.93M 10.70% | 118.93M 10.47% | 121.38M 9.73% |
| EBIT Q2Q % growth | 79.305M 168.06% | 84.66M 215.84% | 87.465M 225.67% | 91.035M 16.06% | 85.272M 7.52% | 88.026M 3.98% | 93.534M 6.94% | 96.492M 5.99% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 1.91 -9.48% | 1.73 | 0.18 | 10.68% |
| Q3 2025 Q2Q % growth | 2.03 27.67% | 1.46 | 0.57 | 38.85% |
| Q2 2025 Q2Q % growth | 2.10 34.62% | 1.53 | 0.57 | 37.25% |
| Q1 2025 Q2Q % growth | 1.72 79.17% | 1.31 | 0.41 | 31.74% |
| Q4 2024 Q2Q % growth | 2.11 34.39% | 1.51 | 0.60 | 39.58% |
| Q3 2024 Q2Q % growth | 1.59 1.27% | 1.28 | 0.31 | 24.67% |
| Q2 2024 Q2Q % growth | 1.56 -17.02% | 1.02 | 0.54 | 53.22% |
| Q1 2024 Q2Q % growth | 0.96 -44.83% | 0.84 | 0.12 | 14.78% |
| Q4 2023 Q2Q % growth | 1.57 -1.88% | 1.22 | 0.35 | 29.07% |
| Q3 2023 Q2Q % growth | 1.57 -10.29% | 1.41 | 0.16 | 11.13% |
| Q2 2023 Q2Q % growth | 1.88 37.23% | 1.63 | 0.25 | 15.20% |
| Q1 2023 Q2Q % growth | 1.74 -4.40% | 1.46 | 0.28 | 19.57% |
| Q4 2022 Q2Q % growth | 1.60 -12.09% | 1.59 | 0.01 | 0.55% |
| Q3 2022 Q2Q % growth | 1.75 -15.46% | 1.49 | 0.26 | 17.25% |
| Q2 2022 Q2Q % growth | 1.37 -27.13% | 1.69 | -0.32 | -19.09% |
| Q1 2022 Q2Q % growth | 1.82 12.35% | 1.82 | 0.00 | 0.06% |
| Q4 2021 Q2Q % growth | 1.82 2.82% | 1.68 | 0.14 | 8.58% |
| Q3 2021 Q2Q % growth | 2.07 8.95% | 1.83 | 0.24 | 12.95% |
| Q2 2021 Q2Q % growth | 1.88 13.94% | 1.67 | 0.21 | 12.39% |
| Q1 2021 Q2Q % growth | 1.62 -10.50% | 1.53 | 0.09 | 5.65% |
| Q4 2020 Q2Q % growth | 1.77 | 1.54 | 0.23 | 14.92% |
| Q3 2020 Q2Q % growth | 1.90 | 1.33 | 0.57 | 42.56% |
| Q2 2020 Q2Q % growth | 1.65 | 1.26 | 0.39 | 30.46% |
| Q1 2020 Q2Q % growth | 1.81 | 1.66 | 0.15 | 9.09% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 535.94M -13.78% | 541.25M | -5.31M | -0.98% |
| Q3 2025 Q2Q % growth | 533.3M -9.48% | 520.65M | 12.65M | 2.43% |
| Q2 2025 Q2Q % growth | 543.573M -6.44% | 553.35M | -9.777M | -1.77% |
| Q1 2025 Q2Q % growth | 599.49M 8.49% | 581.52M | 17.97M | 3.09% |
| Q4 2024 Q2Q % growth | 621.624M 7.97% | 608.57M | 13.054M | 2.15% |
| Q3 2024 Q2Q % growth | 589.131M 7.78% | 586.19M | 2.941M | 0.50% |
| Q2 2024 Q2Q % growth | 580.982M 8.57% | 564.77M | 16.212M | 2.87% |
| Q1 2024 Q2Q % growth | 552.582M -0.61% | 563.3M | -10.718M | -1.90% |
| Q4 2023 Q2Q % growth | 575.744M -0.39% | 574.29M | 1.454M | 0.25% |
| Q3 2023 Q2Q % growth | 546.615M -8.58% | 577.07M | -30.455M | -5.28% |
| Q2 2023 Q2Q % growth | 535.112M -4.61% | 579.9M | -44.788M | -7.72% |
| Q1 2023 Q2Q % growth | 555.946M 2.37% | 576.61M | -20.664M | -3.58% |
| Q4 2022 Q2Q % growth | 578M 69.75% | 590.34M | -12.34M | -2.09% |
| Q3 2022 Q2Q % growth | 597.9M 77.89% | 576.3M | 21.6M | 3.75% |
| Q2 2022 Q2Q % growth | 561M 74.39% | 571.13M | -10.13M | -1.77% |
| Q1 2022 Q2Q % growth | 543.1M 70.79% | 564.23M | -21.13M | -3.74% |
| Q4 2021 Q2Q % growth | 340.5M 6.24% | 326.3M | 14.2M | 4.35% |
| Q3 2021 Q2Q % growth | 336.1M 5.49% | 320.59M | 15.51M | 4.84% |
| Q2 2021 Q2Q % growth | 321.7M 6.03% | 311.54M | 10.16M | 3.26% |
| Q1 2021 Q2Q % growth | 318M -3.23% | 306.92M | 11.08M | 3.61% |
| Q4 2020 Q2Q % growth | 320.5M | 301.24M | 19.26M | 6.39% |
| Q3 2020 Q2Q % growth | 318.6M | 290.39M | 28.21M | 9.71% |
| Q2 2020 Q2Q % growth | 303.4M | 282.23M | 21.17M | 7.50% |
| Q1 2020 Q2Q % growth | 328.6M | 302.23M | 26.37M | 8.73% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -0.44% | 7.65% |
| Revenue | -0.22% | -0.22% | -0.04% | 0.63% |